Pure Extracts (CSE: PULL) is positioned for growth in the commercial cannabis and psychedelics sector based on extensive extraction and production experience. With a team of qualified experts in the space and cutting-edge CO² and ethanol extraction technology, the Company is set up for long-term strategic distribution and product innovation.
The Company’s facility located in Pemberton, BC is built for EU-GMP certification (allowing for international sales) and aims to produce high quality, high purity formulations on a commercial scale. Solvent free, scalable production allows the Company to develop and deliver white-label formulations to service contract sales.
Pure Extracts – our brand is our promise.
PRODUCT PURITY. PRODUCT QUALITY.
Pure Extracts uses CO2 extraction technology to derive full spectrum oil from cannabis biomass. We are an emerging leader in the extraction space offering only the purest quality oil.
Extraction Formulation Brand Development
Our approach is multi-faceted and comprehensive as it includes elements that allow for future growth & expansion, scalability and increased productivity.
Extraction is our business.
Our Vitalis CO² Extraction system produces Full Spectrum Oil (FSO) which is one of the purest and highest quality oils.
We are aiming for a capacity of over 100,000 kg of biomass per year with a technique that has been tried and tested through our teams’ industry experience.
Industry leading quality assurance
Pure Extracts is equipped to offer a variety of different product formulations in the near future, each with specific functionalities.
Product formulations will be of optimal quality, composed of Pure Extracts’ oils and blends of natural ingredients.
Pure Extract’s long-term product expansion plan will be strategically rolled out in three phases.
For more information about our Quality Development Plan download our investor presentation here.
The Extract Market in Canada is still in its infancy
A very limited number of companies are focused on oil extraction. This provides an opportunity for a company with proven ability and perspective to leverage long term experience in the field.
Brand Development is unique to our business model and makes Pure Extracts the only sector-specialized extractor to enter the Canadian Market with a comprehensive Brand Expansion Plan.
The Functional Products & Emerging Psychedelic Compounds markets represent outstanding growth opportunities in uncrowded sectors
Alongside our Cannabis and CBD business lines, Pure Extracts is ideally positioned to rapidly develop and commercialize functional wellness products and psychedelic medicinal products to serve the R&D and drug discovery growth drivers of this exciting new sector.
WHITE LABEL PRODUCTION
As part of its core services, Pure Extracts provides white label solutions from custom formulating oils to sourcing both cannabis and hemp biomass to designing and manufacturing consumer-ready packaging for its customers. Pure Extracts is the one-stop solution for companies licensed to sell specialized oil extracts and for CPG brands seeking licensed manufacturing partners.
Pure Extracts offers specialty processing to Canadian Licensed Producers. Through contract processing, Pure Extracts will provide high quality oil to companies to either re-market or sell under their own brand.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty nine hundred dollars for Pure Extracts Technologies Corp. current news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF Pure Extracts Technologies Corp.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.